RE: Spiked3 Mar 2024 12:48
I'm watching 3 similar type companies at the moment, GDR is one, the other two are Creo Medical and RENX. All three are going to need cash quite soon. But GDR is the one least advanced with commercialisation by a long way. On the other hand, it could be quite interesting when GDR does get its first meaningful sales (if it does) as you could see big increase in share price from that point. Trouble is, to get there they are going to need a lot more cash, so inevitable dilution coming on top of the dilution people have actually already suffered due to this awful death spiral finance. Has anyone ever come across another company in this sector (pharma/biotech) where they've had to use death spiral? Hoping they will do conventional fundraise and this will present a big opportunity to get in.